The award of a multimillion-dollar contract to Scorpius BioManufacturing is directly relevant to NightHawk Biosciences as it indicates potential revenue growth and increased credibility in the biotech manufacturing sector. This news is likely to be viewed positively by investors, as it suggests that the company is expanding its business operations and could lead to increased financial performance in the future. The confidence score reflects the direct involvement of NHWK's subsidiary and the typical market response to such positive contract announcements.